Form 4: Celularity Director LeVien Granted 3,699 RSUs

Celularity Inc. Director Vincent LeVien was granted 3,699 restricted stock units, vesting immediately, under the company's 2021 Equity Incentive Plan.

Summary

• Vincent LeVien, a Director of Celularity Inc. (CELU), acquired 3,699 shares of Class A Common Stock.
• The acquisition occurred on November 19, 2025.
• These shares represent Restricted Stock Units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan.
• Each RSU represents a right to receive one share of the Issuer's Class A common stock.
• The RSUs vested and became exercisable on the date of grant.
• The transaction price was $0.00 per share, typical for RSU grants.
• Following this transaction, Vincent LeVien directly beneficially owns 3,699 shares.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive for corporate governance as it aligns the director's financial interests with those of the shareholders. However, it is a routine compensation event and not indicative of significant operational or financial news.

Positives

• Director Vincent LeVien received an equity grant of 3,699 Restricted Stock Units, aligning his interests with shareholders.
• The RSUs vested immediately on the date of grant, indicating a direct increase in his beneficial ownership.

Negatives

• No specific negative information is disclosed in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

Equity grants, such as Restricted Stock Units (RSUs), are a common form of executive and director compensation in publicly traded companies, particularly in the biotechnology and healthcare sectors where Celularity operates. These grants are designed to align the interests of directors with those of shareholders by providing a direct stake in the company's performance. The immediate vesting of these RSUs is also a common practice for director compensation, often tied to board service.

Comparison to Industry Standards

• The grant of 3,699 Restricted Stock Units to a director is a standard practice for compensating board members in many public companies.
• Similar equity compensation structures are observed at peer companies in the biotech space, where directors often receive a mix of cash and equity for their service.
• The immediate vesting of these RSUs is a common feature for non-employee director grants, ensuring that the director has an immediate ownership stake.
• Specific comparable companies or projects are not detailed in this filing, but the mechanism aligns with general corporate governance practices for director remuneration.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially fostering better decision-making focused on long-term value.

Key Dates

Keywords

Celularity Inc., CELU, Vincent LeVien, Form 4, Restricted Stock Units, RSUs, Equity Incentive Plan, Insider Transaction, Director Compensation, Stock Grant